𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Syndrome shift in the long-term course of schizoaffective disorders

✍ Scribed by A. Marneros; A. Deister; A. Rohde

Publisher
Springer-Verlag
Year
1988
Tongue
English
Weight
635 KB
Volume
238
Category
Article
ISSN
1433-8491

No coin nor oath required. For personal study only.

✦ Synopsis

Seventy-two patients diagnosed as having schizoaffective disorders (Cologne study) were investigated with regard to syndrome shift During longterm follow-up (mean 25 6 years) they had 400 episodes (the duration of an episode being defined as the time between the beginning and end of inpatient or inpatient-like treatment) A total of 61 % of the patients had a polymorphous course, i e displayed more than one type of episode The first syndrome shift was found in the early stages of the course (in 61 % of the cases as early as the second episode, in 84 % at latest by the third episode) Using diagnostic criteria considering the longitudinal approach, 88 % of schizoaffective disorders could be definitively diagnosed as such at the latest by the second episode. The only difference in the course between polymorphous and monomorphous (with only one type of episode) schizoaffective disorders was that the former relapsed more frequently On the basis of the findings of the present study we suggest a longitudinally based dichotomy of schizoaffective disorders into bipolar and unipolar.

πŸ“œ SIMILAR VOLUMES

Long-term course of schizoaffective diso
Long-term course of schizoaffective disorders
✍ A. Marneros; A. Deister; A. Rohde; H. JΓΌnemann; R. Fimmers πŸ“‚ Article πŸ“… 1988 πŸ› Springer-Verlag 🌐 English βš– 850 KB

The present study (Cologne study) investigated the long-term course ( = 25 6 years, minimum 10, maximum 59 years) of 72 schizoaffective patients. The diagnosis was based on the longitudinal approach. All patients were interviewed personally, using the Present State Examination and a pool of question

Long-term course of schizoaffective diso
Long-term course of schizoaffective disorders
✍ A. Marneros; A. Rohde; A. Deister; H. JΓΌnemann; R. Fimmers πŸ“‚ Article πŸ“… 1988 πŸ› Springer-Verlag 🌐 English βš– 537 KB

Length of cycles, intervals, and episodes of 72 schizoaffective patients were investigated (duration of the follow-up means = 25.6 years, minimum 10, maximum 59 years). The average cycle length (time between beginning of an episode and next relapse) was found to be 37.5 months (median). Patients wit

Long-term course of schizoaffective diso
Long-term course of schizoaffective disorders
✍ A. Marneros; A. Rohde; A. Deister; R. Fimmers; H. JΓΌnemann πŸ“‚ Article πŸ“… 1988 πŸ› Springer-Verlag 🌐 English βš– 657 KB

In addition to the findings presented previously, one-half of the 72 investigated schizoaffective patients had an acute onset Onset of manic symptomatology was found to be usually acute Although precipitating factors were found in 76 % of the patients, this was found for only one-third of the 397 ep

Long-term course of restless legs syndro
Long-term course of restless legs syndrome in dialysis patients after kidney transplantation
✍ Juliane Winkelmann; Anette Stautner; Walter Samtleben; Claudia Trenkwalder πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 61 KB

## Abstract Restless legs syndrome (RLS) is a common cause of sleep disturbance and is frequently experienced by hemodialysis patients. Factors triggering the disease in uremia have not yet been identified. To our knowledge, the course of RLS symptoms after kidney transplantation has not been inves

Long-term tolerability of tetrabenazine
Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders
✍ Christopher Kenney; Christine Hunter; Joseph Jankovic πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 90 KB πŸ‘ 1 views

## Abstract We sought to review the long‐term tolerability of tetrabenazine (TBZ) and seek determinants of tolerability in the treatment of hyperkinetic movement disorders. A retrospective chart review was performed on patients treated with TBZ between 1997 and 2004. Efficacy of TBZ was assessed by